Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (241-250 of 328) with videos related to

Pageof 33
Sort By:
Frontiers in Cardiovascular Medicine|December 11, 2020
p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo PathwayRei J Abe, Hannah Savage, Masaki Imanishi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLCPeter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
The Journal of Clinical Investigation|April 26, 2014
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonismYanan Yang, Young-Ho Ahn, Yulong Chen, et al.
Frontiers in Cardiovascular Medicine|March 8, 2021
Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo PathwayRei J Abe, Hannah Savage, Masaki Imanishi, et al.
Medical Physics|October 27, 2024
On the acceptance, commissioning, and quality assurance of electron FLASH unitsAllison Palmiero, Kevin Liu, Julie Colnot, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trialJames Welsh, Hari Menon, Dawei Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2017
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline UpdateMark G Kris, Laurie E Gaspar, Jamie E Chaft, et al.
Journal of Radiation Research|March 13, 2018
Present developments in reaching an international consensus for a model-based approach to particle beam therapyAnussara Prayongrat, Kikuo Umegaki, Arjen van der Schaaf, et al.
Oncology|February 14, 2012
Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapyAkihiro Suzuki, Lianchun Xiao, Yuki Hayashi, et al.
BMC Genomics|December 10, 2014
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionSteven H Lin, Jing Wang, Pierre Saintigny, et al.
Pageof 33

Showing results (241-250 of 328) with videos related to

Sort By:
Pageof 33
Frontiers in Cardiovascular Medicine|December 11, 2020
p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo PathwayRei J Abe, Hannah Savage, Masaki Imanishi, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLCPeter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
The Journal of Clinical Investigation|April 26, 2014
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonismYanan Yang, Young-Ho Ahn, Yulong Chen, et al.
Frontiers in Cardiovascular Medicine|March 8, 2021
Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo PathwayRei J Abe, Hannah Savage, Masaki Imanishi, et al.
Medical Physics|October 27, 2024
On the acceptance, commissioning, and quality assurance of electron FLASH unitsAllison Palmiero, Kevin Liu, Julie Colnot, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trialJames Welsh, Hari Menon, Dawei Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2017
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline UpdateMark G Kris, Laurie E Gaspar, Jamie E Chaft, et al.
Journal of Radiation Research|March 13, 2018
Present developments in reaching an international consensus for a model-based approach to particle beam therapyAnussara Prayongrat, Kikuo Umegaki, Arjen van der Schaaf, et al.
Oncology|February 14, 2012
Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapyAkihiro Suzuki, Lianchun Xiao, Yuki Hayashi, et al.
BMC Genomics|December 10, 2014
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionSteven H Lin, Jing Wang, Pierre Saintigny, et al.
Pageof 33